News Image

Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Provided By PR Newswire

Last update: Aug 18, 2025

WASHINGTON, Aug. 18, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced that it intends to offer $140.0 million aggregate principal amount of convertible senior notes due 2031, subject to market and other conditions. Evolent also expects to grant the initial purchasers in the proposed offering an option to purchase up to an additional $20.0 million aggregate principal amount of notes. The notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").

Read more at prnewswire.com

EVOLENT HEALTH INC - A

NYSE:EVH (10/10/2025, 9:23:37 PM)

After market: 8.0075 +0.07 (+0.85%)

7.94

-0.23 (-2.82%)



Find more stocks in the Stock Screener

Follow ChartMill for more